<DOC>
	<DOCNO>NCT02593786</DOCNO>
	<brief_summary>The purpose study determine whether nivolumab safe effective treatment advance recurrent solid tumor Chinese subject .</brief_summary>
	<brief_title>A Study Safety , Tolerability Pharmacokinetics Nivolumab Chinese Subjects With Previously Treated Advanced Recurrent Solid Tumors</brief_title>
	<detailed_description />
	<mesh_term>Nivolumab</mesh_term>
	<mesh_term>Antibodies , Monoclonal</mesh_term>
	<criteria>For information regard BMS clinical trial participation , please visit www.BMSStudyConnect.com Chinese subject advance recurrent solid tumor Subjects brain metastasis exclude unless clinically stable 2 week time enrollment determine investigator Subjects carcinomatous meningitis exclude</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>